Content
All Posts > Content under Healthcare
Mass Psychology In Action; Instead Of Selling Gilead It Is Time To Take A Closer Look
Article By:
Tactical Investor
Read
Wednesday, September 21, 2016 1:30 PM EDT
Investors once OK with waiting patiently for a Gilead rebound are growing frustrated, even angry, at the company's lack of progress.
In this article: GILD
Clovis Upgraded On Takeover Potential As Pharma M&A Heats Up
IPO Preview - E.L.F. Beauty, Inc.
The Federal Reserve Is Likely To Hold Interest Rates Steady This Week
Article By:
Marvin R Clark
Read
Wednesday, September 21, 2016 5:06 AM EDT
The U.S. economy is on track to grow at a 2.9 percent annualized rate in the third quarter, that according to the latest update of the Atlanta Federal Reserve’s GDP Now forecast model.
Stealth Biotech Rally With Momentum Rising
Article By:
Rod Raynovich
Read
Wednesday, September 21, 2016 2:20 AM EDT
Biotechs stocks continued on their slow but steady upward course headed toward August highs in the case of the IBB and breaking out with the smaller cap weighted XBI.
In this article: AGN, RHHBY, ARIA, IBB, MDVN, SGEN, AMGN, CLVS, GILD, XBI, PBYI, ABBV, SRPT, AGIO, BLUE, TBRA
Dow Jones Industrial Average Today Climbs Ahead Of FOMC Announcement
Article By:
Garrett Baldwin
Read
Tuesday, September 20, 2016 10:31 PM EDT
The Dow Jones Industrial Average pushed higher on Tuesday as investors continue taking a "wait-and-see" approach to the Federal Reserve's policy announcement tomorrow.
With $50M Purchase Of Akarna, Allergan Buys Two Liver Researchers In 24 Hours
BioTime – The Next Biotech Tenbagger ?
Article By:
Taki Tsaklanos
Read
Tuesday, September 20, 2016 9:00 PM EDT
An important indicator of a company’s health is its ability to stand strong during a market correction. One of the biotech companies which has done great since last year’s correction(s) is BioTime.
In this article: BTX
Theravance Biopharma - Chart Of The Day
Article By:
Jim Van Meerten
Read
Tuesday, September 20, 2016 8:22 PM EDT
Since the Trend spotter signaled a buy on 7/27 the sock gained 45.37%.
In this article: TBPH
US Futures, Bonds Rise, Dollar Dips As Fed, BOJ Meetings Begin
Article By:
Tyler Durden
Read
Tuesday, September 20, 2016 6:43 AM EDT
Shifting expectations regarding the outcomes of the BOJ and Fed meetings spurred volatility in financial markets over the past two weeks. A slew of weak American economic data has pushed the probability of a U.S. rate hike to 20 percent.
Sarepta Doubles Market Cap After Long-Awaited Muscular Dystrophy Success
Recent Stock Purchase II September 2016
Article By:
Keith Park
Read
Sunday, September 18, 2016 4:49 PM EDT
With September off to a volatile start, we have been given several new buying opportunities not seen in a while. After all, volatility often equates to opportunity. With that comes the chance to nibble on stocks at better prices, values and yields.
Market's Wildflowers Make Some Traders Sneeze
Article By:
Michele Schneider
Read
Sunday, September 18, 2016 7:16 AM EDT
Bullish allergy sufferers want to see IWM begin and remain strong on Monday. As Friday’s trading range was also inside the range of last Thursday, a move over 122.20 will bring out the nature lovers without experiencing the headache.